Response to Hexet al. Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs-Reference-Cited by-同舟云学术

Response to Hexet al. Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs

Published:2013-03-17 Issue:4 Volume:30 Page:502-503
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:Diabet. Med.

Author:

Waldeyer R.¹,Brinks R.¹,Giani G.¹

Affiliation:

1. German Diabetes Center; Leibniz Center at the Heinrich Heine University; Institute of Biometry and Epidemiology; Düsseldorf Germany

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dme.12058/fullpdf

Reference4 articles.

1. The projected healthcare burden of Type 2 diabetes in the UK from 2000 to 2060;Bagust;Diabet Med,2002

2. The measurement of indirect costs in the health economics evaluation literature. A review;Jacobs;Int J Technol Assess Health Care,1998

3. Eddy DM Hollingworth W Caro JJ Tsevat J McDonald Wong JB DRAFT - Model Transparency and Validation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group http://www.ispor.org/workpaper/modeling_methods/DRAFT-Modeling-Task-Force_Validation-and-Transparency-Report.pdf

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. There is no dose–response relationship between the amount of exercise and improvement in HbA1c in interventions over 12 weeks in patients with type 2 diabetes: a meta-analysis and meta-regression;Acta Diabetologica;2022-08-05

2. Cost of diabetes in Norway 2011;Diabetes Research and Clinical Practice;2016-12

3. Comments on Waldeyeret al. ‘Response to Hexet al. Estimating the current and future costs for Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs’;Diabetic Medicine;2013-03-17